AndrewLPecoraMD
Oncology • Hackensack, NJProfessor of Medicine, UMDNJ - New Jersey Medical School Newark
Dr. Pecora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Prospect Avenue
Hackensack, NJ 07601
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
New York-Presbyterian HospitalResidency, 1983 - 1986
Rutgers New Jersey Medical SchoolClass of 1983
Seton Hall UniversityBS, Biology, Magna Cum Laude, 1975 - 1979
Certifications & Licensure
NY State Medical License 1984 - 2026
VA State Medical License 2023 - 2026- VA State Medical License 2023 - 2026
CO State Medical License 2021 - 2025
FL State Medical License 2020 - 2025
MD State Medical License 2021 - 2025
NJ State Medical License 1989 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsRapid and Complete Response to Combination Anti-CTLA-4 and Anti-PD-1 Checkpoint Inhibitor Therapy in a Patient With Stage IV Refractory End-stage Epithelioid Sarcoma: ...Andrew Pecora, Steven L. Halpern, Melinda Weber, Elli G Paleoudis, David Panush
Journal of Immunotherapy. 2020-11-01 - 1 citationsClinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials.Neil J Shah, Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber
Cancers. 2024-06-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
